Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.

FDA announces supplement recall over risk of heart attack or stroke
Silintan is a dietary supplement marketed as a treatment for joint and body aches. According to a recent analysis by the FDA, however, all lots contained undeclared meloxicam, creating an increased risk of adverse events.
The business of cardiology is changing—and cath labs are working to keep up
Financial literacy is no longer optional for physicians. “If you're not financially viable, you can't function,” explained Nirat Beohar, MD. “The business education is probably just as important as learning a new procedure.”
TAVR, other interventional procedures may provide value for patients with carcinoid heart disease
These patients are typically treated with surgery, but those procedures carry their own risks that clinicians would prefer to avoid.
Cardiovascular health societies share new performance and quality measures for PAD management
The ACC and AHA have published updated performance and quality measures focused on the diagnosis and management of peripheral artery disease. Several other specialty societies, including SCAI and SIR, also participated in the development of this new document.
Cardiologists perform first procedure of its kind to prevent coronary obstruction after TAVR
A vulnerable heart patient required TAVR, but he faced an extremely high risk of coronary obstruction. Leaflet modification and snorkel stenting were not possible, so the group turned to a brand new treatment option: the VECTOR procedure.

FDA warning letter: iRhythm committed multiple violations, failed to report patient deaths in time

“It is your firm’s responsibility to ensure compliance with applicable laws and regulations administered by FDA,” according to the warning letter. These issues, the agency added, “may be symptomatic of serious problems in your firm’s manufacturing and quality management systems.”

Philips' latest collaboration could make xenon MR imaging more widely available

In alliance with Polarean, Philips is rolling out a new MR system with advanced multi-nuclei imaging capabilities that will offer radiologists a detailed evaluation of lung ventilation using xenon gas as a contrast agent.

Antithrombotic therapy after TAVR: Comparing warfarin to DAPT, SAPT

A new retrospective study from the Mayo Clinic focused on patients with no other need for anticoagulation.

Conformal Medical raises $35M to continue development, research of next-gen LAAO device

The new investments were announced as the company continues developing its CLAAS device for sealing the LAA during LAAO procedures.

Juan Diaz, MD, explains why left bundle branch (LBB) conduction pacing is better than conventional sinus node pacing in cardiac synchronization therapy (CRT) for heart failure patients. #HRS #HRS2023 #LBBAP

Left bundle branch pacing: A successful alternative to standard lead placement

Juan C. Diaz, MD, explained why conduction pacing may be the way of the future.

Medical student artificial intelligence training

Medical educators encouraged to equip physicians-to-be with 4 AI competencies

Researchers at the University of Illinois Chicago have developed an elective course that can quickly transform fourth-year medical students from functional AI novices to budding AI experts.

Novo Nordisk close to acquiring French medical device company for $165M

The two companies first started collaborating on diabetes technology in 2021. The acquisition is not yet final, but Novo Nordisk now holds the exclusive negotiation rights.

Virtual reality hypnosis could alter pain management during interventional procedures

The lead-up to radiation therapy can be anxiety-inducing and painful, but experts are optimistic a new relaxation method that is equal parts ancient and futuristic could help to ease patients’ worries.

Clinical

FDA announces supplement recall over risk of heart attack or stroke

The business of cardiology is changing—and cath labs are working to keep up

TAVR, other interventional procedures may provide value for patients with carcinoid heart disease

Cardiovascular health societies share new performance and quality measures for PAD management

Cardiologists perform first procedure of its kind to prevent coronary obstruction after TAVR